Associate Professor Sarah Kummerfeld
Associate Professor Sarah Kummerfeld is the Director of Data Science at the Garvan Institute of Medical Research. She uses genomics to understand human disease and translate findings into clinical diagnostics and treatments. Sarah completed her PhD in Computational Biology at the University of Cambridge, working on protein structure and function prediction. Her postdoctoral research at Stanford University studied the molecular basis of human ageing.
Sarah has worked both in academia and industry, including 10 years as a scientist at Genentech, based in the San Francisco Bay Area. At Genentech, she used large-scale genomics approaches to understand why only some patients respond to treatment and to identify diagnostic biomarkers that predict response to particular drugs. Sarah is dedicated to bringing applying advances in genomics research to benefit patients.
Selected publications
See all publications- 2024The EMBO Journal10.1038/s44318-024-00210-5
Human genomic DNA is widely interspersed with i-motif structures.
- 2024Parkinsonism & Related Disorders10.1016/j.parkreldis.2024.107010
Genome sequencing reanalysis increases the diagnostic yield in dystonia.
- 2024Nature Communications10.1038/s41467-024-46456-9
A universal molecular control for DNA, mRNA and protein expression.
- 2023Cancers10.3390/cancers16010012
Quantitative ctDNA Detection in Hepatoblastoma: Implications for Precision Medicine.
- 2023European Urology Open Science10.1016/j.euros.2023.08.007
Circulating Tumour DNA Biomarkers Associated with Outcomes in Metastatic Prostate Cancer Treated with Lutetium-177-PSMA-617.